Psychogenic dyspnea and hypocapnia in men with ischemic heart disease before and after CABG

The goal of the study was to compare the rate of psychogenic dyspnea (PD) and hypocapnia in patients with ischemic heart disease (IHD) before and after CABG. We studied the objective signs of PD and hypocapnia, such as psychogenic dyspnea coefficient (PDC) and СО <sub>2</sub> concentrati...

Full description

Bibliographic Details
Published in:	Патология кровообращения и кардиохирургия
Main Authors:	O. V. Grishin, N. N. Averko, V. G. Grishin, I. G. Zhilina, Yu. V. Kovalenko
Format:	Article
Language:	English
Published:	Meshalkin National Medical Research Center 2018-06-01
Subjects:	ПСИХОГЕННАЯ ОДЫШКА ГИПОКАПНИЯ ИШЕМИЧЕСКАЯ БОЛЕЗНЬ СЕРДЦА ДЫХАНИЕ
Online Access:	https://journalmeshalkin.ru/index.php/heartjournal/article/view/564

Similar Items

Prevalence of left ventricular hypertrophy myocardium among young people with chronic hypocapnia
by: T G Kovalenko
Published: (2010-12-01)

Prevalence of ischemic heart disease among males with tuberculosis
by: V A Koshechkin, et al.
Published: (2011-09-01)

Conditions and clinical importance of the test with propranololume
by: T S Noskova, et al.
Published: (2009-12-01)

ХИРУРГИЧЕСКОЕ ЛЕЧЕНИЕ МИТРАЛЬНОЙ НЕДОСТАТОЧНОСТИ ИШЕМИЧЕСКОГО ГЕНЕЗА
Published: (2018-01-01)

Suture annuloplasty for surgical treatment of ischemic mitral regurgitation: long-term results
by: М. Л. Гордеев, et al.
Published: (2015-10-01)

State of microcircuiation in cardiac chamber walls in elderly patients with aortic stenosis combined with coronary heart disease
by: A. M. Karaskov, et al.
Published: (2018-06-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

OBSTRUCTIVE CORONARY ATHEROSCLEROSIS AND ISCHEMIC HEART DISEASE: AN ELUSIVE LINK!
by: M. Marzilli, et al.
Published: (2015-12-01)

THE PROBLEM OF THE OPTIMAL PHARMACOTHERAPY CHOICE IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

Sakharnyy diabet i ishemicheskaya bolezn' serdtsa: poiski resheniya
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2005-09-01)

CARDIOPROTECTIVE EFFECT OF PHYSICAL REHABILITATION IN PATIENTS WITH ISCHEMIC-ORIGIN DIASTOLIC DYSFUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION
by: N. P. Lyamina, et al.
Published: (2015-12-01)

PILOT STUDY RESULTS OF THE INFLUENCE OF CITICOLINE AND PIRIBEDIL ON COGNITIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER CORONARY ARTERY BYPASS SURGERY
by: M. M. Petrova, et al.
Published: (2015-09-01)

PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASE
by: N. Yu. Karpova, et al.
Published: (2015-09-01)

CHARACTERISTICS OF THE TYPES OF LEFT VENTRICULAR REMODELING AMONG WORKING AGE MEN WITH ISCHEMIC HEART DISEASE, LIVING IN ONE OF THE MOUNTAIN REGIONS OF AZERBAIJAN
by: N. R. Ismaylova, et al.
Published: (2015-09-01)

IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015-12-01)

A CLINICAL CASE OF VASOSPASTIC ANGINA IN A PATIENT WITH GASTROESOPHAGEAL REFLUX DISEASE
by: Irina Vladimirovna Ponomarenko, et al.
Published: (2023-09-01)

CEREBROVASCULAR PATHOLOGY IN PATIENTS WITH CORONARY HEART DISEASE (NEROIMAGING RESULTS)
by: Irina Danilovna Syrova, et al.
Published: (2023-09-01)

Sakharnyy diabet i ishemicheskaya bolezn' serdtsa: zagadka sul'fanilamidov
by: Andrey Alexeevich Aleksandrov
Published: (2002-09-01)

Особенности клинического течения и фармакотерапии ИБС у женщин. Первые результаты фармакоэпидемиологического исследования ИБС у пациентов Московского региона
Published: (2018-06-01)

Риск развития осложнений при коронарном шунтировании с учетом эффективности легочной вентиляции
by: О. В. Каменская, et al.
Published: (2015-10-01)

Prospective rAndomized, single-blind, mulTicenter control clinical study of sirolimus-eluting coRonary stent “Calypso” vs everolimus-elutIng cOronary stenT “Xience Prime”: design and rationale for “PATRIOT” trial
by: А. А. Прохорихин, et al.
Published: (2016-12-01)

Respiratory function in patients with coronary heart disease in combination with chronic obstructive pulmonary disease
by: А. С. Клинкова, et al.
Published: (2015-10-01)

EXPRESSION OF DE NOVO CERAMIDE SYNTHESIS IN LOCAL HEART FAT DEPO IN PATIENTS WITH CARDIOVASCULAR DISEASES
by: Julia Alexandrovna Dyleva, et al.
Published: (2023-09-01)

DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS. PART II
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS (PART I)
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

THE STATE OF THE CORONARY BED IN CORONARY HEART DISEASE IN PATIENTS WITH HYPOTHYROIDISM
by: Muneer Abdul Rahman, et al.
Published: (2023-12-01)

ОБГРУНТУВАННЯ ТА МЕТОДОЛОГІЯ ОЦІНКИ РІВНЯ СТАНОВЛЕННЯ ЗДОРОВОГО СПОСОБУ ЖИТТЯ У ХВОРИХ НА ІШЕМІЧНУ ХВОРОБУ СЕРЦЯ
by: M. M. Potiazhenko, et al.
Published: (2017-03-01)

Prospective rAndomized, single-blind, mulTicenter study of sirolimus-eluting coRonary stent “Calypso” vs everolimus-eluting cOronary stenT “XiencePrime”: results of the PATRIOT trial
by: A. A. Prokhorikhin, et al.
Published: (2017-11-01)

BISOPROLOL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH CARDIOPULMONARY DISEASES
by: G. N. Gorokchovskaya, et al.
Published: (2016-01-01)

Clinical-echocardiographic results of myocardial revascularization and mitral annuloplasty in patients with I-II degree ischemic mitral regurgitation
by: S. G. Sukhanov, et al.
Published: (2018-06-01)

Effect of medication adherence on the risk of cardiovascular events in outpatients with stable coronary artery disease: results of two-year monitoring
by: S. B. Fitilev, et al.
Published: (2023-04-01)

Polyvascular disease in the real practice of a cardiologist: what we know and where efforts should be concentrated
by: E. V. Shlyakhto
Published: (2024-05-01)

FUNCTIONAL COMPOSITION AND POLYMORPHISM OF THE MITOCHONDRIAL LEUKOCYTE GENOME IN ISCHEMIC HEART DISEASE COMPLICATED BY RHYTHM DISTURBANCES
by: Vyacheslav Andreevich Korepanov, et al.
Published: (2023-09-01)

PHYSICAL METHODS OF REHABILITATION OF PATIENTS WITH CORONARY HEART DISEASE. PROS AND CONS. A LITERARY DIGRESSION INTO THE PROBLEM
by: Алексей Алексеевич Марцияш, et al.
Published: (2022-11-01)

Оценка фармакоэкономической эффективности аторвастатина (липримара) при вторичной профилактике ИБС
Published: (2018-06-01)

DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE
by: S. A. Shalnova, et al.
Published: (2015-09-01)

Multi-center randomized trial on the impact of “CONFIDENCE” communication program aimed at evaluating therapy adherence of patients with registered myocardial infarction who underwent successful revascularization by stenting or thrombolysis after discharg
by: А. Р. Таркова, et al.
Published: (2017-04-01)

Prognostic role of metabolic risk factors (hyperhomocysteinemia) in the development of chronic heart failure
by: Е. Н. Березикова, et al.
Published: (2015-10-01)

МИОКАРДИАЛЬНЫЕ МОСТИКИ: СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ
by: D. A. Korotaev
Published: (2018-06-01)

The influence of catalaza gene polymorphism on the development of cardiovascular pathology in chronic obstructive pulmonary disease
by: T A Uklistaya, et al.
Published: (2012-12-01)